Alkermes's Partner J&J Files sNDA for Bipolar Disorder Drug
                   
redorbit.com     Jul 25, 2008            

Posted on: Friday, 25 July 2008, 12:01 CDT Alkermes has announced that its partner, Johnson & Johnson Pharmaceutical Research & Development submitted a supplemental new drug application for Risperdal Consta to the FDA for approval as monotherapy in the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes in adults. The Risperdal Consta uses Alkermes's proprietary Medisorb technology to deliver and maintain therapeutic medication levels in the body through just one injection every two weeks. Available in 12.5mg, 25mg, 37.5mg and 50mg dose units, Risperdal Consta is approved for the treatment of schizophrenia. Risperdal Consta is marketed by Janssen, division of Ortho-McNeil-Janssen Pharmaceuticals in the US and is manufactured by Alkermes. Elliot Ehrich, chief medical officer of... [read full story]                    


View all news articles about*:
Alkermes Behavior Datamonitor Health Illness Janssen Manic-Depressive Medication Medicines Mental Ortho-McNeil Pharmaceutica Pharmaceutical Pharmaceuticals Psychiatric Remedies Research Sedatives
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

Thomas Weisel Partners Hosts Annual Healthcare Conference

redorbit.com     Sep 3, 2008   2 related          

Posted on: Wednesday, 3 September 2008, 06:00 CDT Thomas Weisel Partners (NASDAQ: TWPG) (TSX: TWP), a global growth-focused investment bank, will host its Annual Healthcare Conference, September 3-5 at the Four Seasons...                    

comments

Alkermes' Corporate Presentation to be Webcast at the Thomas Weisel Partners Healthcare...

yahoo.com     Aug 30, 2008   2 related          

CAMBRIDGE, Mass.----Alkermes, Inc. announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Friday, September 5, 2008 at 9:45 a.m. EDT. The presentation will be webcast from the...                    

comments

                   

Media bias and vaccine compliance

zdnet.com     3 hrs ago          

Posted by Dana Blankenhorn @ 11:50 am Having been a reporter for over 30 years I freely admit there is a media bias. It’s a bias in favor of conflict. (Picture from Alignmap, a patient advocacy blog.) Of course that’s...                    

comments

                   

FDA Posts List of Problem Drugs

time.com     4 hrs ago   74 related          

— The government on Friday began posting a list of prescription drugs under investigation for potential safety problems in an effort to better inform doctors and patients. "My message to patients is this: Don't stop taking...                    

comments